Real-time enrollment status for this solid malignancies clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:00 PM UTC
| NCT Number | NCT06823167 |
| Recruiting Status | Recruiting |
| Condition | Solid Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 190 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Immunome, Inc. |
| Last Updated on CT.gov | August 10, 2026 (Aug 10, 2026) |
As of October 12, 2026: Clinical trial NCT06823167 is currently recruiting participants. This phase1 study for solid malignancies is actively seeking new participants at 19 locations across the United States. The study is sponsored by Immunome, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06823167 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06823167 was last updated Aug 10, 2026 (August 10, 2026). HelloStudys verifies this status automatically.